IGENOMIX USA home - Pioneers in Reproductive Genetics.

Endometrial microbiota composition is associated with reproductive outcome in infertile patients

New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatment strategies.

Learn more! Watch our summary video

Dr. Inma Moreno
Microbiome Jr Director

500
SCIENTIFIC PUBLICATIONS

20
LABS WORLDWIDE

+600
professionals

+4
PATENTS

Genetic Solutions for Specialists

Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.

Preconception

Detect genetic changes in the egg source or sperm source before conception so you can explore options to have a healthy baby

More information

Preimplantation

Help reduce the risk for implantation failure or miscarriage and improve the chances for a healthy pregnancy

More information

Prenatal

Understand whether a pregnancy is at an increased risk for a genetic syndrome

More information

See all services

Education

Fertility

Educational content for your particular reproductive journey

More information

Healthy Pregnancy

Avoid a miscarriage or an implantation failure

More information

Your Baby

Maximize your chances during an IVF treatment

More information

See all services

Research

Igenomix Development

We actively works in research the most advanced techniques to reproductive genetics.

Igenomix Research

Providing solutions to professionals working in reproductive medicine

About Igenomix

Igenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011.

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide, we investigate human reproduction to change the lives of couples who are trying to conceive.

In 2021, Vitrolife acquired Igenomix. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey.

Learn more about Igenomix

Corporate News

More news

Welcome to Vitrolife Group
at ASRM 2023

14 -18 October – New Orleans, Louisiana, USA
Meet us in booth 523

ERA®

HELPING OVERCOME RECURRENT IMPLANTATION FAILURE

^{Endometrial microbiome is essential to improve pregancy outcomes in RIF patients}

Take a look at the latest independent publication showing how EMMA test helps RIF patients’ outcomes.

Endometrial microbiota composition is associated with reproductive outcome in infertile patients

NEW INDEPENDENT ERA PUBLICATION

ERA-guided pETs significantly improves pregnancy rates compared to conventional FETs

Welcome to Vitrolife Group
at ASRM 2023

14 -18 October – New Orleans, Louisiana, USA
Meet us in booth 523

ERA® Endometrial Receptivity Analysis

OFFICIAL STATEMENT

Endometrio Scientific Webinar

Optimal implantation solutions: Preparing a healthy and receptive endometrium.

ERA is now covered by our fertility benefits partners

NEW INDEPENDENT ERA PUBLICATION